Visual Patterns

• • Code-like visual structure was present during the experience, but its focus or perceptual clarity was reduced relative to the participant’s prior reference experiences.
• • The report mentions a possible yellow hue associated with 4-AcO-DMT experiences, but no controlled color measurement or systematic comparison is provided.
• • No detailed characterization is given of symbol morphology, movement, persistence, apparent depth, interaction, or whether the patterns were confined to laser-illuminated surfaces.
• • Because 650 nm and 488 nm lasers were both used, wavelength-specific visual effects cannot be separated from the available report.

Behavioral Patterns

• • The participant characterized the experience as resembling a relatively ordinary mushroom-like psychedelic state while lacking the insight and mystical qualities subjectively associated with other compounds.
• • The report suggests a perceived relationship between overall subjective intensity or clarity and the apparent definition of COR patterns, but this relationship was not measured independently.
• • No systematic interaction test was reported to determine whether attention, gaze, movement, or deliberate intention altered the code.

Technical Patterns

• • The stated technical parameters include a 650 nm laser at 1 mW and a 5 m projection distance; parameters for the 488 nm laser are not specified.
• • The experiment appears to have used a laser pointer and a surface projection, but surface material, beam geometry, diffraction method, ambient illumination, camera settings, and viewing angle are not documented.
• • The linked images may provide additional information, but they were not independently evaluated here; photographs alone would not establish the perceptual properties experienced by the participant.

Scientific Significance

The observation is consistent with the possibility that COR-like visual effects can occur under more than one serotonergic psychedelic condition. However, this experiment cannot determine whether differences in code clarity were caused by pharmacology, dose, metabolism, subjective state, laser wavelength, optical setup, or expectancy. The proposed pharmacokinetic explanation for 4-AcO-DMT should be treated as speculative: the experiment did not measure plasma concentrations, metabolite levels, timing of effects, or receptor activity. Subjective reports of reduced insight or mystical quality are scientifically relevant phenomenological observations, but they do not by themselves demonstrate lower potency or a distinct mechanism.

Methodological Notes

Strengths include chemical verification of the sample after the initial reagent-test discrepancy, documentation of dose, and use of specified laser parameters for at least one wavelength. Major limitations are the single-subject design, absence of a control condition, lack of blinded or randomized wavelength presentation, incomplete reporting of the 488 nm laser specifications, and reliance on retrospective qualitative comparison with prior experiences. The report does not provide administration-to-observation timing, body mass, prior tolerance, co-administered substances, environmental lighting, surface characteristics, dose verification method, or standardized ratings of intensity, clarity, hue, and mystical experience. A 25 mg mass of 4-AcO-DMT cannot be directly interpreted as equivalent to a particular dose of 4-HO-DMT without pharmacokinetic and clinical data.

Recommendations

Future work should use repeated sessions with the same participant and, where ethically and legally appropriate, standardized comparison conditions involving verified compounds rather than relying on retrospective comparisons. Record exact onset and peak timing, dose source and analytical verification, body mass, prior exposure, subjective intensity, visual clarity, hue, code density, and mystical or insight-related ratings at regular intervals. Test 650 nm and 488 nm lasers separately in randomized order, with matched power and carefully documented beam geometry, projection distance, surface, ambient illumination, and viewing angle. Include non-drug and psychedelic control sessions to assess laser-induced diffraction, entoptic effects, expectation, and ordinary visual afterimages. Independent raters could score blinded photographs for recurring structural features, although photographs should be treated as documentation rather than proof of the participant’s perceptual experience. Claims about conversion or residual parent-compound activity require analytical pharmacokinetic studies, such as validated measurement of parent drug and metabolites, and should not be inferred from visual phenomenology alone.